logo
AAT Bioquest

ReadiCleave™ AML Cleavage Buffer *5X Aqueous Solution*

ReadiCleave™ AML Cleavage Buffer provides an optimized formula to effectively remove the fluorescence tags from our ReadiCleave™ AML-labeled biological targets when needed. The removal of the fluorescent ReadiCleave™ AML tags may make the fluorescence imaging more compatible with the downstream analysis of a biological target by other techniques, e.g., MS analysis. Using ReadiCleave™ AML Cleavage Buffer alongside ReadiCleave™ Styramides enables multiplexed fluorescence imaging applications in cells and tissues. ReadiCleave™ Styramides are the new iteration of our PSA products that add the reversible capability to chemically remove the PSA staining on tissue or in cells (if desired) while preserving the integrity of tissue samples.

Example protocol

PREPARATION OF WORKING SOLUTION

ReadiCleave™ AML Cleavage Buffer Working Solution (1X)
  1. To prepare a 1X working solution, add 200 μL of ReadiCleave™ AML Cleavage Buffer into 800 μL of ddH2O, and mix thoroughly.

    Note: For optimal results, use this solution within a few hours of preparation.

SAMPLE EXPERIMENTAL PROTOCOL

  1. Remove the coverslip by briefly dipping the slides into PBS. Then, wash the tissue sample with PBS to eliminate any remaining mounting medium.

  2. Add 100 µL of ReadiCleave™ AML Cleavage Buffer working solution to the tissue or cell samples.

    Note: Add a sufficient amount of ReadiCleave™ AML Cleavage Buffer working solution to ensure that the samples are fully submerged.

  3. Heat the samples at 60°C for 60 minutes.

  4. Remove the ReadiCleave™ AML Cleavage Buffer working solution and briefly rinse the samples with PBST.

  5. Reprocess the tissue samples beginning with the Antigen Retrieval step in your IHC staining protocol.

References

View all 15 references: Citation Explorer
Synthesis and Antiproliferative Activity of 2,4,6,7-Tetrasubstituted-2H-pyrazolo[4,3-c]pyridines.
Authors: Razmienė, Beatričė and Řezníčková, Eva and Dambrauskienė, Vaida and Ostruszka, Radek and Kubala, Martin and Žukauskaitė, Asta and Kryštof, Vladimír and Šačkus, Algirdas and Arbačiauskienė, Eglė
Journal: Molecules (Basel, Switzerland) (2021)
Protein-drug conjugate programmed by pH-reversible linker for tumor hypoxia relief and enhanced cancer combination therapy.
Authors: Zhang, Xican and Feng, Liangzhu and Dong, Ziliang and Xin, Xiaoqian and Yang, Zhijuan and Deng, Dashi and Wagner, Ernst and Liu, Zhuang and Liu, Xiaowen
Journal: International journal of pharmaceutics (2020): 119321
Too Short-Lived or Not Existing Species: N-Azidoamines Reinvestigated.
Authors: Banert, Klaus and Pester, Tom
Journal: The Journal of organic chemistry (2019): 4033-4039
Iridium(iii) complex-based electrochemiluminescent probe for H2S.
Authors: Park, Joonho and Kim, Taemin and Kim, Hoon Jun and Hong, Jong-In
Journal: Dalton transactions (Cambridge, England : 2003) (2019): 4565-4573
Towards molecular electronic devices based on 'all-carbon' wires.
Authors: Moneo, Andrea and González-Orive, Alejandro and Bock, Sören and Fenero, Marta and Herrer, I Lucía and Milan, David C and Lorenzoni, Matteo and Nichols, Richard J and Cea, Pilar and Perez-Murano, Francesc and Low, Paul J and Martin, Santiago
Journal: Nanoscale (2018): 14128-14138
Page updated on July 2, 2025

Ordering information

Price
Unit size
Catalog Number7510
Quantity
Add to cart

Additional ordering information

Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Request quotation

Physical properties

Solvent

Water

Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22

Storage

Freeze (< -15 °C); Minimize light exposure
Fluorescence imaging for the detection of EpCAM in lung adenocarcinoma was conducted using ReadiCleave™ iFluor® 488 Styramide (Cat# 45500), ReadiCleave™ iFluor® 546 Styramide (Cat# 45510), and ReadiCleave™ iFluor® 647 Styramide (Cat# 45520). Images were captured both before and after treatment with ReadiCleave™ AML Cleavage Buffer, providing comparative insights into the effectiveness of the cleavage buffer treatment.
Fluorescence imaging for the detection of EpCAM in lung adenocarcinoma was conducted using ReadiCleave™ iFluor® 488 Styramide (Cat# 45500), ReadiCleave™ iFluor® 546 Styramide (Cat# 45510), and ReadiCleave™ iFluor® 647 Styramide (Cat# 45520). Images were captured both before and after treatment with ReadiCleave™ AML Cleavage Buffer, providing comparative insights into the effectiveness of the cleavage buffer treatment.
Fluorescence imaging for the detection of EpCAM in lung adenocarcinoma was conducted using ReadiCleave™ iFluor® 488 Styramide (Cat# 45500), ReadiCleave™ iFluor® 546 Styramide (Cat# 45510), and ReadiCleave™ iFluor® 647 Styramide (Cat# 45520). Images were captured both before and after treatment with ReadiCleave™ AML Cleavage Buffer, providing comparative insights into the effectiveness of the cleavage buffer treatment.